Page 108 - 《中国药房》2024年13期
P. 108
mononuclear cells in patients with no-option limb ische- Third Military Medical University (SWH2005A109)[J]. J
mia:the randomized,double-blind,placebo-controlled Med Coll PLA,2008,23(2):106-115.
rejuvenating endothelial progenitor cells via transcutaneous [26] HUANG P P,YANG X F,LI S Z,et al. Randomised com‐
intra-arterial supplementation (JUVENTAS) trial[J]. Cir‐ parison of G-CSF-mobilized peripheral blood mono‐
culation,2015,131(10):851-860. nuclear cells versus bone marrow-mononuclear cells for
[18] LI M,ZHOU H,JIN X,et al. Autologous bone marrow the treatment of patients with lower limb arteriosclerosis
mononuclear cells transplant in patients with critical leg obliterans[J]. Thromb Haemost,2007,98(6):1335-1342.
ischemia:preliminary clinical results[J]. Exp Clin Trans‐ [27] ARAI M,YU M S,NAGAI H,et al. Granulocyte colony-
plant,2013,11(5):435-439. stimulating factor:a noninvasive regeneration therapy for
[19] GUPTA P K,CHULLIKANA A,PARAKH R,et al. A treating atherosclerotic peripheral artery disease[J]. Circ J,
double blind randomized placebo controlled phase Ⅰ/Ⅱ 2006,70(9):1093-1098.
study assessing the safety and efficacy of allogeneic bone [28] HUANG P P,LI S Z,HAN M Z,et al. Autologous trans‐
marrow derived mesenchymal stem cell in critical limb plantation of granulocyte colony-stimulating factor-
ischemia[J]. J Transl Med,2013,11:143. mobilized peripheral blood mononuclear cells improves
[20] OZTURK A,KUCUKARDALI Y,TANGI F,et al. Thera‐ critical limb ischemia in diabetes[J]. Diabetes Care,2005,
peutical potential of autologous peripheral blood mono‐ 28(9):2155-2160.
nuclear cell transplantation in patients with type 2 diabetic [29] TATEISHI-YUYAMA E,MATSUBARA H,MUROHARA
critical limb ischemia[J]. J Diabetes Complications,2012, T,et al. Therapeutic angiogenesis for patients with limb
26(1):29-33. ischemia by autologous transplantation of bone-marrow
[21] LOSORDO D W,KIBBE M R,MENDELSOHN F,et al. cells:a pilot study and a randomised controlled trial[J].
A randomized,controlled pilot study of autologous CD34 Lancet,2002,360(9331):427-435.
+
cell therapy for critical limb ischemia[J]. Circ Cardiovasc [30] MATSUI K,MURAKAMI Y,YOSHIOKA T,et al. Thera‐
Interv,2012,5(6):821-830. peutic angiogenesis by transplantation of autologous bone
[22] WALTER D H,KRANKENBERG H,BALZER J O,et al. marrow and peripheral blood mononuclear cells in pa‐
Intraarterial administration of bone marrow mononuclear tients with peripheral arterial disease[J]. Int J Angiol,
cells in patients with critical limb ischemia:a randomized- 2003,12(3):155-161.
start,placebo-controlled pilot trial (PROVASA)[J]. Circ [31] ZHOU B,BI Y Y,HAN Z B,et al. G-CSF-mobilized pe‐
Cardiovasc Interv,2011,4(1):26-37. ripheral blood mononuclear cells from diabetic patients
[23] LU D B,CHEN B,LIANG Z W,et al. Comparison of augment neovascularization in ischemic limbs but with im‐
bone marrow mesenchymal stem cells with bone marrow- paired capability[J]. J Thromb Haemost,2006,4(5):993-
derived mononuclear cells for treatment of diabetic criti‐ 1002.
cal limb ischemia and foot ulcer:a double-blind,rando- [32] DE ANGELIS B,GENTILE P,ORLANDI F,et al. Limb
mized,controlled trial[J]. Diabetes Res Clin Pract,2011, rescue:a new autologous-peripheral blood mononuclear
92(1):26-36. cells technology in critical limb ischemia and chronic
[24] DASH N R,DASH S N,ROUTRAY P,et al. Targeting ulcers[J]. Tissue Eng Part C Methods,2015,21(5):
nonhealing ulcers of lower extremity in human through au‐ 423-435.
tologous bone marrow-derived mesenchymal stem cells [33] ISHIDA A,OHYA Y,SAKUDA H,et al. Autologous pe‐
[J]. Rejuvenation Res,2009,12(5):359-366. ripheral blood mononuclear cell implantation for patients
[25] LU D B,JIANG Y Z,LIANG Z W,et al. Autologous with peripheral arterial disease improves limb ischemia[J].
transplantation of bone marrow mesenchymal stem cells Circ J,2005,69(10):1260-1265.
on diabetic patients with lower limb ischemia supported (收稿日期:2023-12-16 修回日期:2024-06-04)
by the clinical research fund of Southwest Hospital at (编辑:刘明伟)
· 1642 · China Pharmacy 2024 Vol. 35 No. 13 中国药房 2024年第35卷第13期